trending Market Intelligence /marketintelligence/en/news-insights/trending/Utv5ukTDszclEvqoHyR1Qw2 content esgSubNav
In This List

Acucela secures option to buy retinal technology

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Acucela secures option to buy retinal technology

Acucela Inc. secured an exclusive option to acquire EyeMedics LLC's proprietary retinal technology for the treatment of certain eye diseases.

While terms of the agreement were not disclosed, Acucela, a Kubota Pharmaceutical Holdings Co. Ltd. subsidiary, noted that the option was acquired under a research and development agreement with the company.